Results 221 to 230 of about 7,305,993 (392)

Patterns in Tacrolimus Variability and Association with De Novo Donor-Specific Antibody Formation in Pediatric Kidney Transplant Recipients.

Clin J Am Soc Nephrol, 2022
Piburn KH, Sigurjonsdottir VK, Indridason OS, Maestretti L, Patton MV, McGrath A, Palsson R, Gallo A, Chaudhuri A, Grimm PC.   +9 more
europepmc   +1 more source

Donor-Specific Human Leukocyte Antigen Antibody Formation After Allograft Glenoid Reconstruction Occurs But Does Not Impact Clinicoradiographic Outcomes. [PDF]

Am J Sports Med, 2021
Liwski DR, Liwski RS, Wong I.
europepmc   +1 more source

Studies on the Adjuvant Action of Bacterial Endotoxins on Antibody Formation

, 1963
Katharine Merritt, Arthur G. Johnson
openalex   +1 more source

Anti‐PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non‐drug risk factors and evidence for a stoichiometry‐based model of immunization

Journal of Thrombosis and Haemostasis, 2010
Theodore E. Warkentin, Richard J. Cook, V. J. Marder, A. Greinacher   +3 more
semanticscholar   +1 more source

Unveiling unique protein and phosphorylation signatures in lung adenocarcinomas with and without ALK, EGFR, and KRAS genetic alterations

Molecular Oncology, EarlyView.
Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi, Mirjam Balbisi, Simon Sugár, Lóránd Váncza, Eszter Regős, Ilona Kovalszky, Ibolya Laczó, Tünde Harkó, Gábor Kecskeméti, Zoltán Szabó, Judit Moldvay, László Drahos, Lilla Turiák   +12 more
wiley   +1 more source

Understanding and addressing anti-drug antibody formation in tumor necrosis factor-α inhibitor therapy for ankylosing spondylitis. [PDF]

J Rheum Dis
Kim TJ.
europepmc   +1 more source

ANTIBODY FORMATION DURING PREGNANCY

, 1969
Katharine Merritt, Michael Galton
openalex   +1 more source

Studies on the Effect of Interferon on the Formation of Antibody in Mouse Spleen Cells [PDF]

, 1967
Scott Mazzur, Barbara Ellsworth, Kurt Paucker   +2 more
openalex   +1 more source

Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs

Molecular Oncology, EarlyView.
In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza, David James, Emma Creagh, James T. Murray   +3 more
wiley   +1 more source

Anti-HLA antibody formation increases the chances of platelet refractoriness in platelet-transfused patients: a systematic review with meta-analysis. [PDF]

Hematol Transfus Cell Ther
Cabral LJB, Lopes DP, Filho EDSM, Valois RC, Oliveira PCAJ, Mendonça-Mattos PJS.   +5 more
europepmc   +1 more source